Literature DB >> 28304206

Restenosis after stenting in symptomatic vertebral arterial orifice disease and considerations for better outcome.

Jun Young Chang1, Hyun Park2, Oki Kwon3, Moon-Ku Han4.   

Abstract

We have performed stenting in 11 patients with symptomatic vertebral arterial orifice stenosis refractory to medical treatment or impairment in anterior circulation. Three of the 11 patients experienced asymptomatic severe in-stent restenosis or occlusion. Bare metal stents were used in those three patients, two of whom received revascularization therapy. Development of sufficient cervical collateral channels reconstituting the distal vertebral artery was the common feature in patients with asymptomatic in-stent restenosis. In selecting appropriate stents, consideration of mechanical strength and drug-eluting properties of a stent according to characteristics of the target vessel is important to reduce the risk of in-stent restenosis. Any decision to perform revascularization should be based on the presence of abundant cervical collaterals as well as clinical symptoms of vertebrobasilar ischemia.

Entities:  

Keywords:  Vertebral artery; reocclusion; stenosis; stent; treatment

Mesh:

Year:  2017        PMID: 28304206      PMCID: PMC5433599          DOI: 10.1177/1591019916680113

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  18 in total

1.  A new paradigm for plaque stabilization.

Authors:  John A Ambrose; Eulogio E Martinez
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

Review 2.  Diagnosis and management of vertebral artery stenosis.

Authors:  G C Cloud; H S Markus
Journal:  QJM       Date:  2003-01

3.  The impact of lesion length on angiographic restenosis after vertebral artery origin stenting.

Authors:  Y H Lin; Y C Liu; W Y I Tseng; J M Juang; C S Hung; J W Lin; J S Jeng; P K Yip; H L Kao
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-05-06       Impact factor: 7.069

4.  The effect of drug-eluting stents on collateral coronary flow.

Authors:  Carlo di Mario; Konstantinos Dimopoulos
Journal:  J Am Coll Cardiol       Date:  2007-07-23       Impact factor: 24.094

5.  Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis.

Authors:  Yen-Hung Lin; Jyh-Ming Juang; Jiann-Shing Jeng; Ping-Keung Yip; Hsien-Li Kao
Journal:  J Endovasc Ther       Date:  2004-12       Impact factor: 3.487

6.  Coronary collateral function long after drug-eluting stent implantation.

Authors:  Pascal Meier; Rainer Zbinden; Mario Togni; Peter Wenaweser; Stephan Windecker; Bernhard Meier; Christian Seiler
Journal:  J Am Coll Cardiol       Date:  2006-12-13       Impact factor: 24.094

7.  Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry.

Authors:  R J Wityk; H M Chang; A Rosengart; W C Han; L D DeWitt; M S Pessin; L R Caplan
Journal:  Arch Neurol       Date:  1998-04

8.  Drug-eluting stents for the treatment of vertebral artery origin stenosis.

Authors:  Martin Werner; Sven Bräunlich; Matthias Ulrich; Yvonne Bausback; Johannes Schuster; Anina Lukhaup; Spiridon Botsios; Dierk Scheinert; Andrej Schmidt
Journal:  J Endovasc Ther       Date:  2010-04       Impact factor: 3.487

9.  Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective series.

Authors:  G C Cloud; F Crawley; A Clifton; D J H McCabe; M M Brown; H S Markus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

10.  Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? A single-center consecutive case series.

Authors:  Paul T Akins; Charles W Kerber; Ramin S Pakbaz
Journal:  J Invasive Cardiol       Date:  2008-01       Impact factor: 2.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.